| International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency H Farkas, I Martinez‐Saguer, K Bork, T Bowen, T Craig, M Frank, ... Allergy 72 (2), 300-313, 2017 | 223 | 2017 |
| Health‐related quality of life among children with hereditary angioedema B Engel‐Yeger, H Farkas, S Kivity, N Veszeli, KV Kőhalmi, A Kessel Pediatric Allergy and Immunology 28 (4), 370-376, 2017 | 44 | 2017 |
| Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor. H Farkas, KV Kőhalmi, N Veszeli, Z Zotter, K Várnai, L Varga Allergy & Asthma Proceedings 37 (2), 2016 | 40 | 2016 |
| First report of icatibant treatment in a pregnant patient with hereditary angioedema H Farkas, KV Kőhalmi, N Veszeli, F Tóth, L Varga Journal of Obstetrics and Gynaecology Research 42 (8), 1026-1028, 2016 | 35 | 2016 |
| The relationship between anxiety and quality of life in children with hereditary angioedema A Kessel, H Farkas, S Kivity, N Veszeli, KV Kőhalmi, B Engel‐Yeger Pediatric Allergy and Immunology 28 (7), 692-698, 2017 | 34 | 2017 |
| The importance of complement testing in acquired angioedema related to angiotensin-converting enzyme inhibitors Z Balla, Z Zsilinszky, Z Polai, N Andrasi, KV Kőhalmi, D Csuka, L Varga, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (2), 947-955, 2021 | 23 | 2021 |
| Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years H Farkas, KV Kőhalmi Expert Review of Clinical Immunology 14 (6), 447-460, 2018 | 22 | 2018 |
| A follow‐up survey of patients with acquired angioedema due to C1‐inhibitor deficiency Z Pólai, Z Balla, N Andrási, KV Kőhalmi, G Temesszentandrási, ... Journal of Internal Medicine 289 (4), 547-558, 2021 | 20 | 2021 |
| Bacteriuria increases the risk of edematous attacks in hereditary angioedema with C1‐inhibitor deficiency Z Zotter, N Veszeli, KV Kőhalmi, L Varga, É Imreh, G Kovács, M Nallbani, ... Allergy 71 (12), 1791-1793, 2016 | 16 | 2016 |
| How angioedema quality of life questionnaire can help physicians in treating C1-inhibitor deficiency patients? Z Balla, B Ignácz, L Varga, KV Kőhalmi, H Farkas Clinical Reviews in Allergy & Immunology 61 (1), 50-59, 2021 | 15 | 2021 |
| The effect of long-term danazol treatment on haematological parameters in hereditary angioedema KV Kőhalmi, N Veszeli, Z Zotter, D Csuka, S Benedek, É Imreh, L Varga, ... Orphanet Journal of Rare Diseases 11, 1-7, 2016 | 14 | 2016 |
| Clinical characteristics and safety of plasma-derived C1-inhibitor therapy in children and adolescents with hereditary angioedema—a long-term survey H Farkas, KV Kőhalmi, B Visy, N Veszeli, L Varga The Journal of Allergy and Clinical Immunology: In Practice 8 (7), 2379-2383, 2020 | 13 | 2020 |
| Idiopathic nonhistaminergic acquired angioedema versus hereditary angioedema N Andrási, N Veszeli, KV Kőhalmi, D Csuka, G Temesszentandrási, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (4), 1205-1208, 2018 | 13 | 2018 |
| A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum KV Kőhalmi, N Veszeli, L Cervenak, L Varga, H Farkas Immunology Letters 189, 90-93, 2017 | 13 | 2017 |
| Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency Z Zotter, Z Nagy, A Patócs, D Csuka, N Veszeli, KV Kőhalmi, H Farkas Orphanet journal of rare diseases 12, 1-8, 2017 | 12 | 2017 |
| Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry A Valerieva, MT Staevska, V Grivcheva-Panovska, M Jesenak, ... World Allergy Organization Journal 14 (4), 100535, 2021 | 11 | 2021 |
| Pathways of neutrophil granulocyte activation in hereditary angioedema with C1 inhibitor deficiency E Kajdácsi, N Veszeli, B Mező, Z Jandrasics, KV Kőhalmi, AL Ferrara, ... Clinical Reviews in Allergy & Immunology 60, 383-395, 2021 | 10 | 2021 |
| Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema KV Kőhalmi, B Mező, N Veszeli, S Benedek, A Fehér, Á Holdonner, ... International Immunopharmacology 81, 106293, 2020 | 9 | 2020 |
| Investigational drugs in phase I and phase II clinical trials for hereditary angioedema H Farkas, ML Debreczeni, KV Kőhalmi Expert Opinion on Investigational Drugs 27 (1), 87-103, 2018 | 9 | 2018 |
| Complete kinetic follow‐up of symptoms and complement parameters during a hereditary angioedema attack N Veszeli, KV Kőhalmi, E Kajdacsi, D Gulyas, G Temesszentandrasi, ... Allergy 73 (2), 516-520, 2018 | 7 | 2018 |
